Summary
| Direction in Hepatitis C | ↑ Elevated — higher than in the comparison group |
|---|---|
| Category | Hepatic |
| Compared against | acute/chronic HCV infection vs healthy reference range |
| Source | Woo et al. 2024 — doi:10.3390/pathogens13040331 |
| Condition atlas | Hepatitis C Biomarker Atlas |
Other conditions where ALT is reported
| Atlas entry | Direction | Compared against |
|---|---|---|
| Liver enzymes (ALT/AST) in Lyme Disease | ↕ inconsistent | vs HC |
| ALT in NAFLD / MASH (Metabolic-Associated Steatohepatitis) | ↑ elevated | vs NAFLD vs without NAFLD |
See the cross-condition hub: ALT across conditions.
Related Hepatic markers in Hepatitis C
Full list: Hepatitis C Biomarker Atlas.
Frequently asked questions
Is ALT high or low in Hepatitis C?
Elevated. Studies summarised in the OSMF atlas report higher ALT in Hepatitis C than in the reference group of the cited comparison (acute/chronic HCV infection vs healthy reference range). Source: Woo et al. 2024.
Which test measures ALT?
The atlas record does not list a standardised clinical test code (LOINC) for ALT, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.
Is one abnormal ALT result diagnostic of Hepatitis C?
No. No single biomarker is diagnostic of Hepatitis C. ALT findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.
Is ALT specific to Hepatitis C?
No. The same marker is also reported in Lyme Disease, NAFLD / MASH (Metabolic-Associated Steatohepatitis) in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.
Cite this page
Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.